BETTER THERAPEUTICS INC(NASDAQ:BTTX) stock News

BTTX Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: Benzinga - Mentions: HLTH WORX BSGM ATXI ...

12 Health Care Stocks Moving In Friday's After-Market Session

a year ago - By: Benzinga - Mentions: AQST JTAI TG VERB ...

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

a year ago - By: InvestorPlace - Mentions: ZEO JTAI CDLX FSR ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

a year ago - By: Better Therapeutics, Inc.

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

a year ago - By: Better Therapeutics, Inc.

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

a year ago - By: Better Therapeutics, Inc.

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

2 years ago - By: Better Therapeutics, Inc.

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

2 years ago - By: Better Therapeutics Inc.

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

2 years ago - By: Better Therapeutics Inc.

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

2 years ago - By: Better Therapeutics

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

2 years ago - By: Seeking Alpha

Better Therapeutics applies for FDA breakthrough designation for NASH device (NASDAQ:BTTX)

2 years ago - By: Better Therapeutics, Inc.

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

2 years ago - By: Seeking Alpha

Better Therapeutics amends debt facility, implements cost-saving measures (NASDAQ:BTTX)

2 years ago - By: Better Therapeutics, Inc.

Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions

2 years ago - By: Better Therapeutics, Inc.

Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award

2 years ago - By: Better Therapeutics, Inc.

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

2 years ago - By: Better Therapeutics

Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023

2 years ago - By: Better Therapeutics, Inc.

BETTER THERAPEUTICS INC (BTTX) Stock News

BTTX Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Friday's After-Market Session

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

Better Therapeutics applies for FDA breakthrough designation for NASH device (NASDAQ:BTTX)

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

Better Therapeutics amends debt facility, implements cost-saving measures (NASDAQ:BTTX)

Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions

Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023

Better Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conference